NASDAQ · Analyst Forecast

Moderna, Inc. (MRNA) Stock Forecast & Price Target

$216.70 NASDAQ: MRNA Market Cap $87.68B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 10, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Moderna, Inc. (MRNA), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Moderna, Inc., analysts forecast revenue rising from $1.91B in 2025 to $7.58B in 2030; the average estimate for 2030 earnings per share is $3.52; with published estimates ranging from $2.80 to $5.09; 17 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$216.70
Consensus targetThe average of the price targets analysts have published.$140.20
Median targetThe middle target, less affected by a single outlier.$132.50
Highest targetThe most optimistic published target.$305.00
Lowest targetThe most pessimistic published target.$25.00
Difference from priceHow far the consensus target sits from today’s price.-35.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$1.90B$1.91B$1.94B15
2026$2.04B$2.10B$2.26B15
2027$1.96B$2.43B$3.01B16
2028$2.32B$3.38B$6.05B17
2029$4.68B$5.56B$7.47B13
2030$6.39B$7.58B$10.18B8

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$8.40−$7.84−$7.2815
2026−$8.79−$8.42−$8.1015
2027−$7.65−$4.76−$2.9416
2028−$6.83−$2.85$0.2217
2029$0.28$0.36$0.5113
2030$2.80$3.52$5.098

Moderna, Inc. (MRNA) forecast — frequently asked questions

What is the analyst price target for Moderna, Inc.?

Analysts covering Moderna, Inc. (MRNA) have a consensus price target of $140.20, 35.3% below the current price of $216.70. Published targets range from $25.00 to $305.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Moderna, Inc.'s earnings?

The average analyst estimate for Moderna, Inc. (MRNA) earnings per share in 2030 is 3.52, with individual estimates between 2.80 and 5.09.

How much revenue is Moderna, Inc. expected to make?

Analysts forecast Moderna, Inc. (MRNA) revenue of $7.58B in 2030, based on 8 published estimates.

How many analysts cover MRNA?

17 analysts contribute estimates for Moderna, Inc. (MRNA). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastEXEL forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.